Miglustat

CHEMBL1029 Phase 4 Disetujui Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
219.3 g/mol
LogP
-0.6
Phase
4

This oral medication reduces the production of certain fatty substances that accumulate harmfully in cells in people with specific inherited enzyme deficiency disorders. It is used to treat Gaucher disease and Niemann-Pick type C disease.

Berat Molekul

219,2800 g/mol

LogP

-0,60

TPSA

84,20 Ų

Lipinski RO5

Lulus

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO

InChI

InChI=1S/C10H21NO4/c1-2-3-4-11-5-8(13)10(15)9(14)7(11)6-12/h7-10,12-15H,2-6H2,1H3/t7-,8+,9-,10-/m1/s1

Molecular Formula

C10H21NO4

HBD / HBA

4 / 5

Ikatan yang Dapat Dirotasi

4

Atom Berat

15

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

This oral medication reduces the production of certain fatty substances that accumulate harmfully in cells in people with specific inherited enzyme deficiency disorders. It is used to treat Gaucher disease and Niemann-Pick type C disease.

Yes, Miglustat is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1029. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 51634. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.